Scholarlink

<p>Mastitis caused by multidrug-resistant <i>Staphylococcus aureus</i> and its robust biofilm formation poses a significant threat to dairy health. To address this, we developed a novel, eco-friendly therapeutic platform, <i>Carthamus tinctorius</i> L<i>.</i> extract-functionalized lignin nanoparticles (CTLe@LigNPs), using a one-pot ultrasound-assisted protocol. These nanoparticles demonstrated high colloidal stability (71.07 nm, ζ-potential of −21.7 mV), efficient drug loading, and sustained release in both gastric (~ 90%) and intestinal (~ 76%) environments over 24 h. The CTLe@LigNPs showed low cytotoxicity while effectively eradicating planktonic <i>S. aureus</i> (MIC = 125 µg/mL) and significantly disrupting pre-formed biofilms, achieving 71.38% inhibition at the highest concentration tested. In an oral gavage rat mastitis model, a single dose (100 mg/kg) for 7 days ameliorated mastitis symptoms and improved hematological parameters. Mechanistically, CTLe@LigNPs acted as a potent immunomodulator by downregulating <i>TLR2/4</i>, <i>JNK</i>, and <i>MAPK</i> signaling pathways, suppressing pro-inflammatory cytokines such as <i>TNF-α</i> and <i>IL-1β</i> by up to 50%, and elevating antioxidant enzymes (<i>SOD</i>, <i>CAT</i>, <i>GPx</i>) by over 30%. These findings establish CTLe@LigNPs as a promising multifunctional nano-antimicrobial and immunomodulatory platform for treating <i>S. aureus</i> mastitis, warranting further clinical translation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel Lignin Nanoparticles with Enhanced Antimicrobial Activity Against Staphylococcus aureus Mastitis

  • 期刊论文

  • 发表日期：

    2025年11月3日

查看全文
  • Mohamed Sharaf,
  • Rehab E. Mowafy,
  • Sherif M. Ragab,
  • Ayman Ahmed Shehata,
  • Mahran Mohamed Abd El-Emam,
  • Chen-Guang Liu,
  • Azza S. El-Demerdash

摘要

Mastitis caused by multidrug-resistant Staphylococcus aureus and its robust biofilm formation poses a significant threat to dairy health. To address this, we developed a novel, eco-friendly therapeutic platform, Carthamus tinctorius L. extract-functionalized lignin nanoparticles (CTLe@LigNPs), using a one-pot ultrasound-assisted protocol. These nanoparticles demonstrated high colloidal stability (71.07 nm, ζ-potential of −21.7 mV), efficient drug loading, and sustained release in both gastric (~ 90%) and intestinal (~ 76%) environments over 24 h. The CTLe@LigNPs showed low cytotoxicity while effectively eradicating planktonic S. aureus (MIC = 125 µg/mL) and significantly disrupting pre-formed biofilms, achieving 71.38% inhibition at the highest concentration tested. In an oral gavage rat mastitis model, a single dose (100 mg/kg) for 7 days ameliorated mastitis symptoms and improved hematological parameters. Mechanistically, CTLe@LigNPs acted as a potent immunomodulator by downregulating TLR2/4, JNK, and MAPK signaling pathways, suppressing pro-inflammatory cytokines such as TNF-α and IL-1β by up to 50%, and elevating antioxidant enzymes (SOD, CAT, GPx) by over 30%. These findings establish CTLe@LigNPs as a promising multifunctional nano-antimicrobial and immunomodulatory platform for treating S. aureus mastitis, warranting further clinical translation.